Truist Financial Maintains Amedisys(AMED.US) With Hold Rating, Announces Target Price $101
Truist Financial Keeps Their Hold Rating on Amedisys (AMED)
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
UnitedHealth's $33B Deal With Hospice Provider Blocked By DOJThe Deal Values Amedisys at $101 a Share
Express News | Optum - Will Vigorously Defend Against Doj’s Legal Action Aimed at Blocking Proposed Deal of Optum and Amedisys
Sector Update: Health Care Stocks Slipping Tuesday Afternoon